Brief: Kymera Therapeutics Announces Pricing Of Upsized $602 Million Public Offering At $86 Per Share
10/12/2025 04:31
Dec 9 (Reuters) - Kymera Therapeutics Inc KYMR.O: KYMERA THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $602 MILLION PUBLIC OFFERING KYMERA THERAPEUTICS INC - SELLING 7,000,000 SHARES AT $86 PER SHARE Source text: ID:nGNXbmD4Qf Further company coverage: KYMR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kymera Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Kymera Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kymera Therapeutics Q2 collaboration revenue more than doubles, beats estimates
Brief: Kymera Therapeutics Q2 EPS USD -0.62
Brief: Kymera Therapeutics Appoints Terence Rooney, MD, As Chief Medical Officer